Human LAP (TGF-beta 1) Protein, Tag Free (MALS verified)
分子別名(Synonym)
LAP (TGF-beta 1),LAP (TGFB1),TGFB1,CED,DPD1,LAP,TGF-beta-1,TGFB
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human LAP (TGF-beta 1), Tag Free (LAP-H5213) is expressed from human 293 cells (HEK293). It contains AA Leu 30 - Arg 278 (Accession # P01137-1 (C33S)).
Predicted N-terminus: Leu 30
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries no "tag".
The protein has a calculated MW of 28.5 kDa. The protein migrates as 33-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
轉(zhuǎn)化生長(zhǎng)因子β1(TGFB1)也稱為TGF-β1、CED、DPD1、TGFB。是細(xì)胞因子轉(zhuǎn)化生長(zhǎng)因子β超家族的多肽成員。它是一種分泌蛋白,執(zhí)行許多細(xì)胞功能,包括控制細(xì)胞生長(zhǎng)、細(xì)胞增殖、細(xì)胞分化和凋亡。TGFB1蛋白有助于控制細(xì)胞的生長(zhǎng)和分裂(增殖),這是細(xì)胞成熟以執(zhí)行特定功能(分化)、細(xì)胞運(yùn)動(dòng)(運(yùn)動(dòng))和細(xì)胞自毀(凋亡)的過程。TGFB1蛋白遍布全身,在出生前的發(fā)育、血管的形成、肌肉組織和身體脂肪發(fā)育的調(diào)節(jié)、傷口愈合和免疫系統(tǒng)功能中發(fā)揮作用。TGFB1在構(gòu)成骨骼的組織中含量特別豐富,它有助于調(diào)節(jié)骨骼生長(zhǎng),并在細(xì)胞間空間(細(xì)胞外基質(zhì))形成的復(fù)雜晶格中含量特別高。在細(xì)胞內(nèi),這種蛋白質(zhì)被關(guān)閉(失活),直到它收到化學(xué)信號(hào)變得活躍。TGFB1在控制免疫系統(tǒng)中起著重要作用,在不同類型的細(xì)胞或不同發(fā)育階段的細(xì)胞上顯示出不同的活性。大多數(shù)免疫細(xì)胞(或白細(xì)胞)分泌TGFB1。TGFB1已被證明與TGF-β受體1、LTBP1、YWHAE、EIF3I和Decorin相互作用。
關(guān)鍵字: TGF-beta 1;TGFB1蛋白;TGFB1重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。